Hosted on MSN6d
FDA approves drug application for Lupin’s heart failure therapy
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Medscape2d
Introduction to the New Prescription Drug Labeling by the Food and Drug Administration
The contents section serves as a navigational ... products approved or submitted for approval under an abbreviated new drug application (ANDA) depends on the labeling of the listed drug referenced ...
the-future-of-commerce3d
2025 life sciences trends: Reducing complexity, improving healthcare
Life sciences trends 2025 include the rise of personalized therapies, supply chain resilience, compliance, and collaboration ...
Medscape4d
Medscape Editorial Policies
This content is produced by a team of seasoned ... based primarily on US drug approvals and applications. New drug monographs are created following approval of such drugs by the US Food and ...
Plastics Technology2d
High Quality PCR With Mechanical Recycling Is Within Reach
Despite growing interest in using PCR materials in packaging to reduce virgin plastic use, producers and recyclers report ...
Politico Europe3d
PFAS: Working toward a sustainable future while protecting patient care
Pharma and medtech companies are invited to join a project on PFAS exposure, emissions and end-of-life management in the ...
FDA Approves First New Non-Opiod Painkiller in Decades
Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Nature12h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The New York Times6d
In China, Rare Dissent Over a Program to Save on Drug Costs
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality. By Alexandra Stevenson and Zixu Wang Reporting from Hong Kong A rare ...